Failures in Alzheimer’s Vaccine Efforts Result of Research Errors, Scientist Says, And Suggests Ways of Correcting Them

Failures in Alzheimer’s Vaccine Efforts Result of Research Errors, Scientist Says, And Suggests Ways of Correcting Them
All failed attempts to produce a viable vaccine against amyloid-beta in Alzheimer’s disease have one thing in common — they all used vaccine adjuvants that elicit the wrong kind of immune response, says Qantu Therapeutics' president and CSO, Dante J. Marciani, in a sweeping retrospective analysis that covers errors in past and current development efforts and recommends ways of correcting them. According to the analysis, A retrospective analysis of the Alzheimer's disease vaccine progress - The critical need for new development strategies," vaccine development in Alzheimer’s started off on the wrong foot. The Phase 2 clinical trial of the first vaccine, called AN1792, wa
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *